Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

Andre F S Amaral et al. Int J Epidemiol. .
No abstract available

Keywords: Chronic obstructive pulmonary disease; global health; non-communicable respiratory disease.

PubMed Disclaimer

Conflict of interest statement

D.M. is a consultant to GlaxoSmithKline, AstraZeneca and Up-to-Date, a shareholder of GlaxoSmithKline, and an expert witness on behalf of people suing the tobacco industry. T.S. has received honoraria from AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim for lecturing and attendance at advisory boards over the past 3 years, and has published research with GlaxoSmithKline in the past year. W.C.T. reports grants from Canadian Institute of Heath Research (CIHR/Rx&D Collaborative Research Program Operating Grants 93326) with industry partners Astra Zeneca Canada, Boehringer-Ingelheim Canada, GlaxoSmithKline Canada, Merck, Novartis Pharma Canada, Nycomed Canada, Pfizer Canada, during the conduct of the CanCOLD study; personal fees from GlaxoSmithKline, Canada, and from Astrazeneca, Canada, outside the submitted work.

Figures

Figure 1.
Figure 1.
Burden of Obstructive Lung Disease (BOLD) study sites
Figure 2.
Figure 2.
Selection of participants in the Burden of Obstructive Lung Disease (BOLD) cohort
See this image and copyright information in PMC

References

    1. Davis RM, Novotny TE.. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:S82–84. - PubMed
    1. Siafakas NM, Vermeire P, Pride NB. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398–420. - PubMed
    1. Cunningham J, Condon JR.. Premature mortality in aboriginal adults in the Northern Territory, 1979-1991. Med J Aust 1996;165:309–12. - PubMed
    1. Burney P, Patel J, Minelli C. et al. ; BOLD Collaborative Research Group. Prevalence and population-attributable risk for chronic airflow obstruction in a large multinational study. Am J Respir Crit Care Med 2021;203:1353–65. - PMC - PubMed
    1. Murray CJ, Lopez AD.. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269–76. - PubMed

Publication types